Skip to main content
Fig. 5 | Molecular Neurodegeneration

Fig. 5

From: Autoimmune antibody decline in Parkinson’s disease and Multiple System Atrophy; a step towards immunotherapeutic strategies

Fig. 5

Plasma samples from MSA patients have significantly reduced binding capability to α-synuclein monomer. Average percentage (± − SEM) of inhibition (PI) of individual plasma samples with free α-synuclein monomer on plates coated with 5 μg/mL of α-synuclein monomer. Plasma samples from Parkinson’s Disease (PD-blue squares), Multiple System Atrophy (MSA-green, triangles) patients and normal controls (NC-black, circles) were tested at two different dilutions a 1:100 and b 1:200. The line represents the fitting of a two-site model to the data (*p < 0.05)

Back to article page
\